Given that IL-6 and IL-8 expression induced by acid may lead to mucosal injury in GERD, thus inhibition of the pro-inflammatory cytokine pathways like NF-kB may act as an important therapeutic target for treating esophageal inflammation. Here, IL6 is linked to gastroesophageal reflux disease.